Research progress of immune checkpoint inhibitors in the treatment of acral melanoma

Research progress of immune checkpoint inhibitors in the treatment of acral melanoma

In recent years, immune checkpoint inhibitor (ICI) has led to substantial advances in the treatment of recurrent or metastatic advanced cutaneous melanoma (CM), significantly prolonging overall survival. However, due to the biological heterogeneity across melanoma subtypes, the degree of immune resp...

Full description

Saved in:
Bibliographic Details
Main Author: QIAN Jiajia, RUAN Cong, LIU Jiyong, XU Rui
Format: Article
Language:English
Published: Editorial Office of China Oncology 2025-07-01
Series:Zhongguo aizheng zazhi
Subjects:
|acral melanoma|immune checkpoint inhibitor|neoadjuvant|adjuvant|combination therapy
Online Access:https://www.china-oncology.com/fileup/1007-3639/PDF/1755061433654-2067063117.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items